We are live on ! Find out more
B

Braidwell Portfolio holdings

AUM $3B
1-Year Est. Return 46.72%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.98B
AUM Growth
–
Cap. Flow
+$1.68B
Cap. Flow %
56.29%
Top 10 Hldgs %
33.01%
Holding
88
New
63
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$82M
2
BIIB icon
Biogen
BIIB
+$71.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$71.3M
4
NTRA icon
Natera
NTRA
+$66.8M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$61.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 56.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
1
Glaukos
GKOS
$9.02B
$72.6M 2.43%
+1,661,851
New +$82M
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$71.5M 2.4%
+3,341,300
New +$71.3M
BIIB icon
3
Biogen
BIIB
$29.9B
$69.9M 2.34%
+252,542
New +$71.3M
PCVX icon
4
Vaxcyte
PCVX
$7.89B
$65.3M 2.19%
+1,362,278
New +$53.5M
NTRA icon
5
Natera
NTRA
$37.5B
$65.1M 2.18%
+1,621,012
New +$66.8M
CRNX icon
6
Crinetics Pharmaceuticals
CRNX
$8.86B
$63.5M 2.13%
+3,469,674
New +$61.1M
XENE icon
7
Xenon Pharmaceuticals
XENE
$6.32B
$61M 2.05%
+1,548,110
New +$56.4M
ISRG icon
8
Intuitive Surgical
ISRG
$121B
$59.2M 1.98%
+223,120
New +$54.4M
DCPH
9
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$53.6M 1.8%
+3,271,513
New +$53.2M
NVRO
10
DELISTED
NEVRO CORP.
NVRO
$47.2M 1.58%
+1,192,298
New +$49.6M
IRTC icon
11
iRhythm Holdings
IRTC
$3.59B
$46.6M 1.56%
+497,667
New +$54.2M
ALGN icon
12
Align Technology
ALGN
$12B
$46.4M 1.55%
+219,930
New +$44M
OM icon
13
Outset Medical
OM
$74.9M
$44M 1.47%
+113,637
New +$32M
KIDS icon
14
OrthoPediatrics
KIDS
$485M
$41.5M 1.39%
+1,044,699
New +$43.5M
ACRS icon
15
Aclaris Therapeutics
ACRS
$730M
$37.7M 1.26%
+2,393,985
New +$38.5M
PEN icon
16
Penumbra
PEN
$12.5B
$36.2M 1.21%
+162,828
New +$31.8M
AMGN icon
17
Amgen
AMGN
$203B
$34.4M 1.15%
+131,100
New +$35.1M
BLU
18
DELISTED
BELLUS Health Inc.
BLU
$33.8M 1.13%
+4,112,494
New +$38.3M
LEGN icon
19
Legend Biotech
LEGN
$4.3B
$32.9M 1.1%
+658,101
New +$31.9M
SNDX icon
20
Syndax Pharmaceuticals
SNDX
$1.84B
$31.6M 1.06%
+1,242,802
New +$29M
MRUS
21
DELISTED
Merus
MRUS
$30.9M 1.04%
+1,998,084
New +$35.2M
TVTX icon
22
Travere Therapeutics
TVTX
$5.33B
$30.6M 1.03%
+1,455,585
New +$30.8M
KRYS icon
23
Krystal Biotech
KRYS
$9.88B
$28.4M 0.95%
+358,056
New +$26.6M
HLVX
24
DELISTED
HilleVax
HLVX
$27.1M 0.91%
+1,620,216
New +$29.3M
DAWN
25
DELISTED
Day One Biopharmaceuticals
DAWN
$26.8M 0.9%
+1,246,539
New +$25.6M
1
2 3

Similar funds

NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
SGI
Swan Global Investments Durango, Colorado $3B AUM 15.66% 1-Year Est. Return
SP
SurgoCap Partners New York $2.99B AUM 39.34% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

Braidwell's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Braidwell, which disclosed 88 positions worth $2.98B. Its ten largest holdings account for 33% of the portfolio.

Its largest position is Glaukos: 1,661,851 shares worth $72.6M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets.

  • Braidwell's largest Q4 2022 buy was Glaukos: 1,661,851 shares worth $72.6M.
  • Braidwell's ten largest holdings make up 33% of its $2.98B portfolio in Q4 2022.
  • Braidwell disclosed 88 positions in Q4 2022, its first 13F filing on record.

Based on Braidwell's 13F filing for Q4 2022, filed 14 Feb 2023.